Requip is a prescription medication primarily used to treat symptoms of Parkinson's disease, such as stiffness, tremors, muscle spasms, and poor muscle control. It is also prescribed for the treatment of moderate to severe Restless Legs Syndrome (RLS). The active ingredient in Requip is ropinirole, which belongs to a class of drugs known as dopamine agonists. These medications work by mimicking the effects of dopamine, a naturally occurring substance in the brain that helps control movement. By increasing dopamine activity, Requip can help improve motor function and decrease the uncomfortable symptoms associated with its indicated conditions. It is important for patients to follow their healthcare provider's instructions when taking Requip, as the dosage may need to be adjusted over time to achieve the best results with minimal side effects. When using REQUIP, a medication commonly prescribed for Parkinson's disease and Restless Legs Syndrome (RLS), it's crucial to adhere strictly to your doctor's instructions and thoroughly read the label accompanying the medicine. This ensures you understand the correct dosage and any potential interactions with other medications you might be taking. Inform your doctor about all other medicines you are using to avoid adverse interactions. Common side effects of REQUIP include dizziness, nausea, and fatigue, which may impair your ability to drive or operate heavy machinery safely. More rare side effects can include hallucinations and sudden sleep onset. Given these possibilities, caution is advised when engaging in activities that require alertness, such as driving. Always prioritize safety and report any unusual symptoms or side effects to your doctor immediately. Following these precautions will help manage your condition effectively while minimizing risks.
Your cart contains products from a separate order category. Adding this product will remove those items from your cart.
Important Supply & Pricing Update about GLP-1 Medications
Due to manufacturer-driven price increases from Eli Lilly and other suppliers, prices for GLP-1 medications including Mounjaro have risen significantly. Global supply constraints may also result in slightly longer lead times.
We remain committed to securing the best possible pricing and supply for our customers and will continue to provide updates as the situationĀ evolves.